Invention Grant
- Patent Title: Intranasal oxytocin treatment to improve schizophrenia
- Patent Title (中): 鼻内催产素治疗改善精神分裂症
-
Application No.: US13812850Application Date: 2011-07-30
-
Publication No.: US09585935B2Publication Date: 2017-03-07
- Inventor: David Feifel
- Applicant: David Feifel
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Gavrilovich, Dodd & Lindsey LLP
- Agent Joseph R. Baker, Jr.
- International Application: PCT/US2011/046046 WO 20110730
- International Announcement: WO2012/016229 WO 20120202
- Main IPC: A61K38/11
- IPC: A61K38/11 ; A61K9/00
Abstract:
The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analog thereof having a beneficial effect.
Public/Granted literature
- US20130231279A1 OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE Public/Granted day:2013-09-05
Information query
